A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary ...

Over the coming months, the Pulmonary Fibrosis Foundation's 2025 PFF Walk will aim to raise more than $1 million for the ...

Clinical trials are an important part of IPF research, says columnist Sam Kirton, but we need people willing to participate in them.

Because certain IPF and post-transplant medications can cause sun sensitivity, skin protection is crucial, says columnist Sam Kirton.

Living with pulmonary fibrosis, columnist Ann Reynoso writes, means no more independent, spontaneous days with enough energy ...

Palliative care is a specialized care approach aimed at improving the quality of life for both seriously ill patients and their families. In PF, it is focused on relieving the common symptoms of the ...

FIBRONEER-IPF (NCT05321069) enrolled 1,177 patients, ages 40 and older, at several sites in the U.S., Canada, South America, Europe, Asia, and Australia. Full efficacy and safety data will be ...

Breakthrough therapy designation is intended to expedite the development and review of medicines for serious or life-threatening diseases. The decision is based on preliminary clinical evidence ...

Antioxidant molecules can protect cells against oxidative stress, an imbalance between the production of potentially damaging molecules called free radicals and the ability of cells to detoxify ...